David Entin Email

Senior Director, Corporate Development . GlycoMimetics

Current Roles

Employees:
50
Revenue:
$8.4M
About
At GlycoMimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. Our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow's breakthrough treatments. GlycoMimetics is a clinical-stage biotechnology company. We use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. Since the company's inception in 2003, we have developed a robust, diversified product pipeline. We are a public company traded on the NASDAQ under the symbol GLYC.
GlycoMimetics Address
9708 Medical Center Drive
Rockville, MD
United States
GlycoMimetics Email

Past Companies

GlycoMimeticsRSenior Director, Corporate Development
GlycoMimetics, Inc.Director, Corporate Contracts, Licensing and Business Development
EntreMed, Inc.Director of Business Development

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.